Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

864

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Kidney Cancer
Interventions
BIOLOGICAL

girentuximab

Given IV

OTHER

placebo

Given IV

Trial Locations (56)

1424

Complejo Medico de la Policia Federal Argentina, Buenos Aires

1426

Instituto Alexander Fleming, Cramer

1886

Hospital Zonal General de Agudos, Ranelagh

2000

Centro de Oncologia Rosario, Rosario

10029

Mount Sinai School of Medicine, New York

10466

Our Lady of Mercy Medical Center Comprehensive Cancer Center, The Bronx

11530

AccuMed Research Associates, Garden City

12209

Community Care Physicians, PC at Urological Institute of NENY, Albany

12601

Hudson Valley Urology, PC, Poughkeepsie

17604

Urological Associates of Lancaster, Limited, Lancaster

19718

Helen F. Graham Cancer Center at Christiana Hospital, Newark

20770

Werner-Francis Urology Associates, LLC, Greenbelt

27403

Alliance Urology Specialists - Greensboro, Greensboro

28078

Carolina BioOncology Institute, Huntersville

30322

Winship Cancer Institute of Emory University, Atlanta

30901

Augusta Oncology Associates - Walton Way, Augusta

32114

Atlantic Urological Associates - Daytona Beach, Daytona Beach

32224

Mayo Clinic - Jacksonville, Jacksonville

32308

Southeastern Research Group, Tallahassee

37209

Urology Associates, Nashville

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

45219

University of Cincinnati, Cincinnati

46804

Northeast Indiana Urology, PC, Fort Wayne

63110

Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, St Louis

70006

Hematology and Oncology Specialists, LLC - Metairie, Metairie

71106

Regional Urology, LLC, Shreveport

75246

Mary Crowley Medical Research Center at Sammons Cancer Center, Dallas

78229

Urology San Antonio, PA - Fredericksburg, San Antonio

78503

Urology Associates of South Texas, PA, McAllen

89135

Nevada Cancer Institute, Las Vegas

94115

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

98101

CCOP - Virginia Mason Research Center, Seattle

99508

Anchorage

90095-1781

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

83814-2668

North Idaho Urology - Coeur d'Alene, Coeur d'Alene

52242-1002

Holden Comprehensive Cancer Center at University of Iowa, Iowa City

71130-3932

Feist-Weiller Cancer Center at Louisiana State University Health Sciences, Shreveport

02215

Beth Israel Deaconess Medical Center, Boston

01805

Lahey Clinic Medical Center - Burlington, Burlington

14263-0001

Roswell Park Cancer Institute, Buffalo

43214-3998

Riverside Methodist Hospital Cancer Care, Columbus

37232-6838

Vanderbilt-Ingram Cancer Center, Nashville

05405-0110

Vermont Cancer Center at University of Vermont, Burlington

Unknown

Unidad Oncologica Del Neuquen, Neuquén

S300FFV

Clinical Especializada ISIS, Santa Fe

30240-060

Biocancer Centro de Pesq e Trat de Cancer SA, Belo Horizonte

40170-070

Nucleo de Oncologia da Bahia, Bahia

20230-130

Instituto Nacional de Cancer, Rio de Janeiro

01308-050

Hospital Sirio-Libanes, São Paulo

04023-900

Universidade Federal de Sao Paulo, São Paulo

V8V 3N1

G. Steinhoff Clinical Research, Victoria

L8N 4A6

McMaster Institute of Urology at St. Joseph Healthcare, Hamilton

L6H 3PI

Male Health Centre - Oakville, Oakville

L6J 3J3

CMX Research, Incorporated, Oakville

M6A 3B5

Male Health Centre - North York, Toronto

J4V 2H1

Hopital Charles Lemoyne, Greenfield Park

Sponsors
All Listed Sponsors
lead

Heidelberg Pharma AG

INDUSTRY